Salomon Stemmer - Israel | Professional Profile | LinkedIn
Twitter-এ OncologyEducation: "Dr. Salomon Stemmer provides an update of Namodenoson in patients with Child-Pugh B hepatocellular carcinoma in this video from #ASCO19: https://t.co/82i6FiWc4l https://t.co/SlkSpAAMot" / টুইটার
Bevacizumab plus paclitaxel versus bevacizumab plus capecitabine as first-line treatment for HER2-negative metastatic breast can
A Phase I, Dose-Finding Study of Sorafenib in Combination with Gemcitabine and Radiation Therapy in Patients with Unresectable P
Cancer Patients See Sustained Response to COVID Vaccine | MedPage Today
Prospective Long-Term Follow-Up of Pulmonary Diffusion Capacity Reduction Caused by Dose-Dense Chemotherapy in Patients with Breast Cancer
WP2: Resilience Definition and operationalization
Prospective Long-Term Follow-Up of Pulmonary Diffusion Capacity Reduction Caused by Dose-Dense Chemotherapy in Patients with Breast Cancer
Past Seminars - Health Care Management
Systematic Review and Meta-Analysis on the Role of Chemotherapy in Advanced and Metastatic Neuroendocrine Tumor (NET)
Milind Javle | MD Anderson Cancer Center
Rachel C Jankowitz, MD profile | PennMedicine.org
ReCAP: Perspectives of Patients, Caregivers, and Medical Staff on Greetings in Oncology Practice: A Prospective Survey | JCO Oncology Practice
THE 1ST ISRAELI NEUROENDOCRINE TUMORS CONGRESS
Ten-year clinical outcomes in N0 ER+ breast cancer patients with Recurrence Score-guided therapy | npj Breast Cancer
White Matter Changes in Patients with Breast Cancer Treated with High-Dose Chemotherapy and Autologous Bone Marrow Support
Can posttraumatic growth after breast cancer promote positive coping?—A cross‐lagged study - Hamama‐Raz - 2019 - Psycho-Oncology - Wiley Online Library
Collaterals
Ribociclib as First-Line Therapy for HR-Positive, Advanced Breast Cancer | NEJM
ESMO Congress 2021 Speakers Template
Transnational cancer research lab | Felsenstein Medical Research Center
Congreso Apanac on Twitter: "Uno de los conferencistas invitados al Congreso es el Dr. Salomon Stemmer, Jefe de Investigación e Innovación en el Instituto de Oncología del Centro Davidoff del Centro Médico
Cancer Patients Develop 'Adequate' Immune Response to COVID Vax | MedPage Today
Evaluating the Quality of Colorectal Cancer Care across the Interface of Healthcare Sectors
Overall Survival with Ribociclib plus Letrozole in Advanced Breast Cancer | NEJM
